Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-17

FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's generic oral contraceptive product containing drospirenone and ethinyl estradiol under an Original Application (ANDA204296).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DROSPIRENONE AND ETHINYL ESTRADIOL (drospirenone and ethinyl estradiol)

Snippet

ORIG AP for DROSPIRENONE AND ETHINYL ESTRADIOL (DROSPIRENONE AND ETHINYL ESTRADIOL)